Dr. Reuben was charged with submitting fabricated research in a 2007 pain management study of patients who had knee surgery. The test, funded by a $73,000 research grant, was supposed to measure the effects of the drug Celebrex on reducing post-operative pain.
A 2008 routine audit by Baystate revealed the test was never conducted, even though Dr. Reuben had published studies suggesting otherwise. After further investigation, the hospital discovered Dr. Reuben had misrepresented findings in 21 other studies dating back to 1996.
Dr. Reuben lost his medical license and has been banned from conducting drug research.
Read more about Dr. Reuben’s sentencing.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
